Last edition
News about Industrial talks
F&S notes global medical imaging & informatics market thrives with AI and cloud to spur growth
Frost & Sullivan has noted that the healthcare sector's emphasis on meeting its Quadruple Aim goal of cost reduction, clinical outcomes, enhance the patient and caregiver experience, and improve the work-life of its medical professionals, nurses and paramedics encourages the medical imaging and informatics industry to use advanced technologies
Industrial talks | 12/08/2021 | By Darshana | 243
Cipla receives US FDA approval for generic Durezol
Cipla Limited has received final approval for its Abbreviated New Drug Application (ANDA) for difluprednate ophthalmic emulsion 0.05% from the United States Food and Drug Administration (FDA)
Industrial talks | 12/08/2021 | By Darshana | 218
IPC flags safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction
The Indian Pharmacopoeia Commission (IPC) which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) has flagged safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction.
Industrial talks | 09/08/2021 | By Darshana | 529
Kite inks research pact with Appia Bio to develop allogeneic cell therapies
Kite, a Gilead Company and Appia Bio, an early stage biotechnology company, announced a collaboration and license agreement to research and develop HSC-derived cell therapies directed toward hematological malignancies. Under the partnership, Kite and Appia Bio will develop chimeric antigen receptor
Industrial talks | 07/08/2021 | By Darshana | 192
Accelerate Diagnostics announced that the new IVD configuration of its Accelerate PhenoTest BC kit has been CE marked and is ready for use in Europe
Industrial talks | 06/08/2021 | By Darshana | 279
NPPA directs manufacturers and importers of five medical devices to submit data every quarter
The National Pharmaceutical Pricing Authority (NPPA) has directed the manufacturers and importers of the five medical devices it has recently imposed a trade margin cap of 70 per cent to submit quarterly stock details within 10 days from the completion of the quarter, till the time the notification is in force
Industrial talks | 30/07/2021 | By Darshana | 346
CDSCO classifies 208 medical devices in various categories
The Central Drugs Standard Control Organisation (CDSCO) has announced classification of medical devices pertaining to rehabilitation, physical support, dermatology and plastic surgery and interventional radiology under the provisions of Medical Devices Rules, 2017
Industrial talks | 28/07/2021 | By Darshana | 205
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and share equally in any future potential profits
Industrial talks | 28/07/2021 | By Darshana | 240
Glenmark Life Sciences to expand geographical markets and CDMO business
Glenmark Life Sciences Limited, a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (API) in chronic therapeutic areas, is planning to expand geographical markets and to grow contract development and manufacturing organization (CDMO) business
Industrial talks | 27/07/2021 | By Darshana | 731
DoP amends Drug Price Control Order to add price list norms for medical devices
The Department of Pharmaceuticals has amended the drug price regulation to include the form in which the medical devices firms have to submit a price list to the drug regulatory authority
Industrial talks | 24/07/2021 | By Darshana | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy